Eisai
4523.T
#2112
Rank
โ‚น822.91 B
Marketcap
โ‚น2,919
Share price
0.79%
Change (1 day)
19.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: โ‚น49.45 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น49.45 Billion, an increase over its 2022 earnings that were of -โ‚น2.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023โ‚น49.45 B-2404.04%
2022-โ‚น2.15 Billion-103.6%
2021โ‚น59.67 B-39.81%
2020โ‚น99.14 B7.44%
2019โ‚น92.28 B17.22%
2018โ‚น78.72 B86.16%
2017โ‚น42.28 B-23.52%
2016โ‚น55.29 B26.97%
2015โ‚น43.54 B22.3%
2014โ‚น35.61 B-46.07%
2013โ‚น66.03 B-21.85%
2012โ‚น84.48 B-20.59%
2011โ‚น106.39 B-8.91%
2010โ‚น116.81 B19.21%
2009โ‚น97.98 B